- Review
Heart transplantation has made tremendous progress since its first clinical use in 1968 and has enabled survival of many patients with intractable heart failure. A pioneer of the Swiss heart transplant programme looks back.
2018 09 - 6 articles
Heart transplantation has made tremendous progress since its first clinical use in 1968 and has enabled survival of many patients with intractable heart failure. A pioneer of the Swiss heart transplant programme looks back.
Background: In ACS patients who are treated with a primary percutaneous coronary intervention (pPCI), stent thrombosis is a serious and potentially lethal complication. We analysed the occurrence, risk factors and outcomes of angiographically proven...
Pacemaker implantation is indicated when symptoms can clearly be attributed to bradyarrhythmias or in asymptomatic patients with type 2 second degree atrioventricular (AV) block or complete heart block. First-degree AV block or Mobitz 1 second-degree...
Fabry disease – a rare but important cause of left ventricular hypertrophy. Fabry disease (synonym: Morbus Fabry, Anderson Fabry disease) is an Xlinked lysosomal storage disease due to a deficient activity of alpha-galactosidase A. This leads to path...
FDG-PET/CT enables direct visualisation of inflammatory activity and may represent a useful tool for diagnosis, risk stratification and therapy monitoring in patients with pericarditis.
Education – the mission of the ESC. The education of trainees, postgraduate and established cardiologists alike has always been a critical component of the mission of the European Society of Cardiology (ESC) [...]